Harvard Bioscience
HBIO
HBIO
99 hedge funds and large institutions have $192M invested in Harvard Bioscience in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
2.42% less ownership
Funds ownership: 69.78% → 67.36% (-2.4%)
17% less capital invested
Capital invested by funds: $232M → $192M (-$40.4M)
Holders
99
Holding in Top 10
1
Calls
$112K
Puts
$18K
Top Buyers
| 1 | +$3.77M | |
| 2 | +$2.02M | |
| 3 | +$510K | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
+$485K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$472K |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.37M | |
| 3 | -$1.1M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$948K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$867K |